Journal
Journal of Clinical Investigation
Publication Date
5-15-2026
Volume
136
Issue
10
First Page
e198519
Document Type
Open Access Publication
DOI
10.1172/JCI198519
Rights and Permissions
Urano F, Marshall BA, Hurst S, Robichaux-Viehoever A, Ahmadi S, Hershey T, Van Stavern G, Cruz Bravo P, Powers Carson J, Pesko J, Fox K, Erpelding N, Bedrosian CL. Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome. J Clin Invest. 2026 May 15;136(10):e198519. doi: 10.1172/JCI198519. © 2026, Urano et al. This is an open access article published under the terms of the Creative Commons Attribution 4.0 International License.
Recommended Citation
Urano, Fumihiko; Marshall, Bess A.; Hurst, Stacy; Robichaux-Viehoever, Amy; Ahmadi, Saumel; Hershey, Tamara; Van Stavern, Gregory; Cruz Bravo, Paulina; Powers Carson, Jennifer; Pesko, John; Fox, Kelly; Erpelding, Nathalie; and Bedrosian, Camille L, "Phase II trial of sodium phenylbutyrate and taurursodiol in Wolfram syndrome." Journal of Clinical Investigation. 136, 10. e198519 (2026).
https://digitalcommons.wustl.edu/oa_4/7735
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
